BioNTech SE ADR sell WaltFinance
Start price
13.10.21
/
10%
€211.40
Target price
13.10.24
€130.00
Performance (%)
-61.97%
Price
15:18
€80.40
Summary
This prediction is currently active. Massive losses of -61.97% have been the result for the SELL prediction by WaltFinance. This prediction currently runs until 13.10.24. The prediction end date can be changed by WaltFinance at any time. WaltFinance has 10% into this prediction This prediction was marked as speculative and is excluded from WaltFinance's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioNTech SE ADR | 7.896% | 7.896% | 243.124% |
| iShares Core DAX® | -1.670% | -1.001% | 10.864% |
| iShares Nasdaq 100 | -4.184% | -1.145% | 37.458% |
| iShares Nikkei 225® | -4.967% | -5.783% | 18.828% |
| iShares S&P 500 | -2.834% | -0.572% | 25.875% |
According to WaltFinance what are the pros and cons of BioNTech SE ADR for the foreseeable future?
Pros
Cons
Revenue decline/stagnation expected
Increased challenges to pay loans and raise capital
Risky balance sheet
Low dividend yield expected
Little Investments for future growth
Few uniques
Below average Marketposition
Little known brand
Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Bad rating
negative Cash Flow expected
ROE lower than 10% per year
Higher risks for its business
Below average Management
Bad culture
Little innovation
Dependend from some customers or products
Growths slower than the competition
Sustainability is little important
high free float
Significant cyclical dependencies
Business model of the past or high risk
Comments by WaltFinance for this prediction
In the thread Biontech SE diskutieren
Sell mit Kursziel 130,0